INTEGRATIVE NETWORK PHARMACOLOGY AND MOLECULAR DOCKING REVEAL MULTI-TARGET THERAPEUTIC POTENTIAL OF ABELMOSCHUS ESCULENTUS PHYTOCONSTITUENTS AGAINST POLYCYSTIC OVARY SYNDROME
International Journal of Drug Delivery Technology · 26.06.2026 · 16 (58s)
DOI: 10.25258/ijddt.16.58s.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 26.06.2026. Verfasst von Purva B. Jadhav und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder characterized by hormonal imbalance, insulin resistance, and chronic inflammation. This study aimed to evaluate the therapeutic potential of phytoconstituents from Abelmoschus esculentus using an integrated network pharmacology and molecular docking approach. Compounds were screened based on pharmacokinetic properties, drug-likeness, and toxicity, followed by target prediction and intersection with PCOS-related genes. Protein–protein interaction (PPI) network analysis and pathway enrichment identified key targets, including EGFR, STAT3, TLR4, and MTOR, involved in PI3K–AKT, MAPK, JAK–STAT, and mTOR signaling pathways. Molecular docking demonstrated that Vitamin E exhibited the highest binding affinity, particularly with EGFR (−8.0 kcal/mol), followed by Vernolic acid and Linolenic acid. Additionally, selected compounds showed favorable pharmacokinetic and safety profiles. To the best of our knowledge, limited studies have explored the multi-target therapeutic potential of Abelmoschus esculentus phytoconstituents against PCOS using an integrated network pharmacology and molecular docking approach. These findings highlight their multi-target therapeutic potential; however, further experimental validation is required.
Zitieren
APA
Jadhav, P. B., Dhole, V. R., Burli, S. C., Kumbhar, P. S., Ingavale, S. B. S. B., Rohile, V. Y., Salunkhe, A. P., & Pandit, S. (2026). INTEGRATIVE NETWORK PHARMACOLOGY AND MOLECULAR DOCKING REVEAL MULTI-TARGET THERAPEUTIC POTENTIAL OF ABELMOSCHUS ESCULENTUS PHYTOCONSTITUENTS AGAINST POLYCYSTIC OVARY SYNDROME. International Journal of Drug Delivery Technology, 16(58s). https://doi.org/10.25258/ijddt.16.58s.2
Vancouver
Jadhav PB, Dhole VR, Burli SC, Kumbhar PS, Ingavale SBSB, Rohile VY, et al. INTEGRATIVE NETWORK PHARMACOLOGY AND MOLECULAR DOCKING REVEAL MULTI-TARGET THERAPEUTIC POTENTIAL OF ABELMOSCHUS ESCULENTUS PHYTOCONSTITUENTS AGAINST POLYCYSTIC OVARY SYNDROME. International Journal of Drug Delivery Technology. 2026;16(58s). doi:10.25258/ijddt.16.58s.2
BibTeX
@article{Jadhav2026,
author = {Jadhav, Purva B. and Dhole, Vikas R. and Burli, S. C. and Kumbhar, Prashant S. and Ingavale, Swapnil B. Swapnil B. and Rohile, Vinayak Y. and Salunkhe, Asawari P. and Pandit, Shivani},
title = {INTEGRATIVE NETWORK PHARMACOLOGY AND MOLECULAR DOCKING REVEAL MULTI-TARGET THERAPEUTIC POTENTIAL OF ABELMOSCHUS ESCULENTUS PHYTOCONSTITUENTS AGAINST POLYCYSTIC OVARY SYNDROME},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {58s},
doi = {10.25258/ijddt.16.58s.2}
}
EUVIMED